Objective: To determine if cancer patients experience variability in incidence or management of emergency general surgery (EGS) conditions compared tononcancer patients.
Background: The true frequency and natural history of EGS conditions among cancer patients have not been characterized.
Methods: We utilized surveillance, epidemiology, and end results-medicare data from January 2006 to December 2016 to compare patients with breast, prostate, and lung cancer to a noncancer cohort. Patients were followed from the date of cancer diagnosis, or index date for noncancer patients, to the development of an EGS condition, death, or last follow-up. We assessed the cumulative incidence of EGS conditions over time, and fit multivariable Cox proportional hazards models to evaluate the impact of time-dependent surgical intervention on mortality.
Results: We identified 322,756 patients with breast (N=82,147), lung (N=128,618), and prostate cancer (N=111,991) and 210,429 noncancer patients. Cancer patients had a higher incidence of an EGS condition within the first year after diagnosis (4.8% vs 3.2%), with lung (6.8%) and breast cancer (4.0%) showing consistent trends. Cancer patients were less likely to undergo surgery (13% vs 14%, P =0.005), though this varied by cancer type and EGS conditions. Patients with breast (HR: 1.27, 95% CI: 1.17-1.39) and lung cancer (HR: 3.27, 95% CI: 3.07-3.48) were more likely to die within 30 days of an EGS diagnosis.
Conclusions: Cancer patients experience a higher incidence of EGS conditions within the first year following diagnosis but are less likely to undergo surgery. Future research is needed to explore the interplay between EGS conditions, their management, receipt of intended oncologic therapy, and resulting outcomes.
Keywords: cancer; emergency general surgery; population data.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.